Announcement

The American Association for Cancer Research (AACR) is deeply concerned that the Administration’s recent actions are threatening the National Institutes of Health (NIH) and its lifesaving mission to accelerate progress […]

On Friday, January 10th, leading cancer research experts convened for a workshop focused on Solving the Early Detection and Diagnosis of Recalcitrant Cancers. The event, jointly hosted by the Lustgarten […]

WATCH – Get the latest insights into groundbreaking advancements and the exciting road ahead in pancreatic cancer research.

Dr. David Slavin In September 2017, Dr. David Slavin, then a 54-year-old Chiropractor from Long Island, started experiencing stomach pain and just didn’t feel right, and he feared the worst. […]

It is with a heavy heart that we remember the life of valiant Lustgarten Foundation advocate, friend, and honorary chairman of our Corporate Advisory Board, President Jimmy Carter, 39th President […]

It is with profound sadness that we honor the life and legacy of Charles Dolan, Co-founder and Chairman Emeritus of the Lustgarten Foundation, following his passing on Saturday, December 28th, […]

Break Through Cancer has launched a collaborative cohort for a Phase 1 study of RMC-6236, a compound developed by Revolution Medicines that is designed to suppress multiple RAS proteins that […]

Learn how our LABS (Lustgarten Advancing Breakthrough Science) program fosters collaboration and accelerates breakthroughs in research from three of our six internationally renowned Lustgarten lab leaders — Tyler Jacks, PhD, […]